Review





Similar Products

94
Hycult Biotech human c3a elisa kit
Human C3a Elisa Kit, supplied by Hycult Biotech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+c3a/C3a%2C+Human%2C+ELISA+kit/us12595270-839-0-4
Average 94 stars, based on 1 article reviews
human c3a elisa kit - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

96
ATCC human hepatocellular carcinoma hepg2 c3a cells
Human Hepatocellular Carcinoma Hepg2 C3a Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+c3a/C3A/pmc13753295-25-13-27
Average 96 stars, based on 1 article reviews
human hepatocellular carcinoma hepg2 c3a cells - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

94
MedChemExpress human c3a
<t>C3a‐C3aR</t> signaling was identified as a potential key regulator associated with NETs formation. (A, C) Heatmap of genes enriched regarding the NETs formation and complement cascade ( n = 3). C3 and C3aR are involved in complement cascade and NETs formation. (B) KDA provides that C3aR is a key driver in influencing the expression of other genes. (D) Quantification of mRNA of C1qa, C3, C3aR, C4, and C5 using RT‐qPCR 3 days after stroke ( n = 6 in the sham group, and n = 7 in the stroke group). (E) WB bands in 2 groups 3 days after stroke. (F–H) Protein expression of C1q, C3, and C3aR normalized to β‐actin ( n = 4). (I) C3aR expressed on the neutrophils. Scale bar = 50 μm or 20 μm (zoom). (J) The colocalization experiment showing the fluorescent signals of C3aR and HIS48. The density plot illustrates the fluorescence intensity in colocalized regions, indicating a spatial overlap. (K) Co‐IP results of C3aR and C3, showing an association between C3‐derived material and C3aR in tissue lysates. Stroke group versus sham group, data as mean ± SEM. * p < 0.05, ** p < 0.01, and *** p < 0.001.
Human C3a, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+c3a/C3a/pmc13748817-133-2-4
Average 94 stars, based on 1 article reviews
human c3a - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

93
Hycult Biotech mouse monoclonal anti c3 c3a
<t>C3a‐C3aR</t> signaling was identified as a potential key regulator associated with NETs formation. (A, C) Heatmap of genes enriched regarding the NETs formation and complement cascade ( n = 3). C3 and C3aR are involved in complement cascade and NETs formation. (B) KDA provides that C3aR is a key driver in influencing the expression of other genes. (D) Quantification of mRNA of C1qa, C3, C3aR, C4, and C5 using RT‐qPCR 3 days after stroke ( n = 6 in the sham group, and n = 7 in the stroke group). (E) WB bands in 2 groups 3 days after stroke. (F–H) Protein expression of C1q, C3, and C3aR normalized to β‐actin ( n = 4). (I) C3aR expressed on the neutrophils. Scale bar = 50 μm or 20 μm (zoom). (J) The colocalization experiment showing the fluorescent signals of C3aR and HIS48. The density plot illustrates the fluorescence intensity in colocalized regions, indicating a spatial overlap. (K) Co‐IP results of C3aR and C3, showing an association between C3‐derived material and C3aR in tissue lysates. Stroke group versus sham group, data as mean ± SEM. * p < 0.05, ** p < 0.01, and *** p < 0.001.
Mouse Monoclonal Anti C3 C3a, supplied by Hycult Biotech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+c3a/C3%2FC3a%2C+Human%2C+mAb+474/pm42986452-73-18-22
Average 93 stars, based on 1 article reviews
mouse monoclonal anti c3 c3a - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

93
R&D Systems spheroids
<t>C3a‐C3aR</t> signaling was identified as a potential key regulator associated with NETs formation. (A, C) Heatmap of genes enriched regarding the NETs formation and complement cascade ( n = 3). C3 and C3aR are involved in complement cascade and NETs formation. (B) KDA provides that C3aR is a key driver in influencing the expression of other genes. (D) Quantification of mRNA of C1qa, C3, C3aR, C4, and C5 using RT‐qPCR 3 days after stroke ( n = 6 in the sham group, and n = 7 in the stroke group). (E) WB bands in 2 groups 3 days after stroke. (F–H) Protein expression of C1q, C3, and C3aR normalized to β‐actin ( n = 4). (I) C3aR expressed on the neutrophils. Scale bar = 50 μm or 20 μm (zoom). (J) The colocalization experiment showing the fluorescent signals of C3aR and HIS48. The density plot illustrates the fluorescence intensity in colocalized regions, indicating a spatial overlap. (K) Co‐IP results of C3aR and C3, showing an association between C3‐derived material and C3aR in tissue lysates. Stroke group versus sham group, data as mean ± SEM. * p < 0.05, ** p < 0.01, and *** p < 0.001.
Spheroids, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+c3a/Recombinant+Human+Complement+Component+C3a+Protein%2C+CF/pm42962879-356-38-33
Average 93 stars, based on 1 article reviews
spheroids - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

96
ATCC c3a human liver cells
<t>C3a‐C3aR</t> signaling was identified as a potential key regulator associated with NETs formation. (A, C) Heatmap of genes enriched regarding the NETs formation and complement cascade ( n = 3). C3 and C3aR are involved in complement cascade and NETs formation. (B) KDA provides that C3aR is a key driver in influencing the expression of other genes. (D) Quantification of mRNA of C1qa, C3, C3aR, C4, and C5 using RT‐qPCR 3 days after stroke ( n = 6 in the sham group, and n = 7 in the stroke group). (E) WB bands in 2 groups 3 days after stroke. (F–H) Protein expression of C1q, C3, and C3aR normalized to β‐actin ( n = 4). (I) C3aR expressed on the neutrophils. Scale bar = 50 μm or 20 μm (zoom). (J) The colocalization experiment showing the fluorescent signals of C3aR and HIS48. The density plot illustrates the fluorescence intensity in colocalized regions, indicating a spatial overlap. (K) Co‐IP results of C3aR and C3, showing an association between C3‐derived material and C3aR in tissue lysates. Stroke group versus sham group, data as mean ± SEM. * p < 0.05, ** p < 0.01, and *** p < 0.001.
C3a Human Liver Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+c3a/C3A/pm42716800-46-0-8
Average 96 stars, based on 1 article reviews
c3a human liver cells - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

94
Hycult Biotech mab clone2898
<t>C3a‐C3aR</t> signaling was identified as a potential key regulator associated with NETs formation. (A, C) Heatmap of genes enriched regarding the NETs formation and complement cascade ( n = 3). C3 and C3aR are involved in complement cascade and NETs formation. (B) KDA provides that C3aR is a key driver in influencing the expression of other genes. (D) Quantification of mRNA of C1qa, C3, C3aR, C4, and C5 using RT‐qPCR 3 days after stroke ( n = 6 in the sham group, and n = 7 in the stroke group). (E) WB bands in 2 groups 3 days after stroke. (F–H) Protein expression of C1q, C3, and C3aR normalized to β‐actin ( n = 4). (I) C3aR expressed on the neutrophils. Scale bar = 50 μm or 20 μm (zoom). (J) The colocalization experiment showing the fluorescent signals of C3aR and HIS48. The density plot illustrates the fluorescence intensity in colocalized regions, indicating a spatial overlap. (K) Co‐IP results of C3aR and C3, showing an association between C3‐derived material and C3aR in tissue lysates. Stroke group versus sham group, data as mean ± SEM. * p < 0.05, ** p < 0.01, and *** p < 0.001.
Mab Clone2898, supplied by Hycult Biotech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+c3a/C3%2FC3a%2C+Human%2C+mAb+2898/bio_rxiv__64898__2026__06__18__733111-271-15-18
Average 94 stars, based on 1 article reviews
mab clone2898 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

99
ATCC human hepatocellular carcinoma hepg2 c3a
Effect of 10 Gy X‐ray on viability of NIH‐3T3, B16.F10, MDA‐MB‐231, and <t>HepG2</t> cells. Blue: untreated controls; Pink: irradiated cells. Cell counts were conducted at 24, 48, and 72 h post‐treatment. Statistical analysis was performed using two‐way ANOVA with Tukey's post hoc test: p < 0.05 (*), p < 0.005 (**), p < 0.0005 (***), p < 0.0001 (****), n = 3. Note: Y ‐axes are scaled independently for each cell line to account for differences in baseline growth, allowing clearer visualization of treatment effects. Tumor cell counts and representative images can be found in Appendix Table and Figure .
Human Hepatocellular Carcinoma Hepg2 C3a, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+c3a/Hep+G2/pmc13112599-173-15-25
Average 99 stars, based on 1 article reviews
human hepatocellular carcinoma hepg2 c3a - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

99
Roche human complement c3a elisa kit invitrogen bms2089 human complement c5a elisa kit invitrogen bms2088 kapa hifi hotstart readymix kapa biosystems
Effect of 10 Gy X‐ray on viability of NIH‐3T3, B16.F10, MDA‐MB‐231, and <t>HepG2</t> cells. Blue: untreated controls; Pink: irradiated cells. Cell counts were conducted at 24, 48, and 72 h post‐treatment. Statistical analysis was performed using two‐way ANOVA with Tukey's post hoc test: p < 0.05 (*), p < 0.005 (**), p < 0.0005 (***), p < 0.0001 (****), n = 3. Note: Y ‐axes are scaled independently for each cell line to account for differences in baseline growth, allowing clearer visualization of treatment effects. Tumor cell counts and representative images can be found in Appendix Table and Figure .
Human Complement C3a Elisa Kit Invitrogen Bms2089 Human Complement C5a Elisa Kit Invitrogen Bms2088 Kapa Hifi Hotstart Readymix Kapa Biosystems, supplied by Roche, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+c3a/KAPA+HiFi+Kit/pm41997144-265-207-225
Average 99 stars, based on 1 article reviews
human complement c3a elisa kit invitrogen bms2089 human complement c5a elisa kit invitrogen bms2088 kapa hifi hotstart readymix kapa biosystems - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

96
ATCC human c3a
Effect of 10 Gy X‐ray on viability of NIH‐3T3, B16.F10, MDA‐MB‐231, and <t>HepG2</t> cells. Blue: untreated controls; Pink: irradiated cells. Cell counts were conducted at 24, 48, and 72 h post‐treatment. Statistical analysis was performed using two‐way ANOVA with Tukey's post hoc test: p < 0.05 (*), p < 0.005 (**), p < 0.0005 (***), p < 0.0001 (****), n = 3. Note: Y ‐axes are scaled independently for each cell line to account for differences in baseline growth, allowing clearer visualization of treatment effects. Tumor cell counts and representative images can be found in Appendix Table and Figure .
Human C3a, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+c3a/C3A/pm41771535-188-0-4
Average 96 stars, based on 1 article reviews
human c3a - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

Image Search Results


C3a‐C3aR signaling was identified as a potential key regulator associated with NETs formation. (A, C) Heatmap of genes enriched regarding the NETs formation and complement cascade ( n = 3). C3 and C3aR are involved in complement cascade and NETs formation. (B) KDA provides that C3aR is a key driver in influencing the expression of other genes. (D) Quantification of mRNA of C1qa, C3, C3aR, C4, and C5 using RT‐qPCR 3 days after stroke ( n = 6 in the sham group, and n = 7 in the stroke group). (E) WB bands in 2 groups 3 days after stroke. (F–H) Protein expression of C1q, C3, and C3aR normalized to β‐actin ( n = 4). (I) C3aR expressed on the neutrophils. Scale bar = 50 μm or 20 μm (zoom). (J) The colocalization experiment showing the fluorescent signals of C3aR and HIS48. The density plot illustrates the fluorescence intensity in colocalized regions, indicating a spatial overlap. (K) Co‐IP results of C3aR and C3, showing an association between C3‐derived material and C3aR in tissue lysates. Stroke group versus sham group, data as mean ± SEM. * p < 0.05, ** p < 0.01, and *** p < 0.001.

Journal: CNS Neuroscience & Therapeutics

Article Title: C3a‐ C3aR Signaling Modulates Neutrophil Extracellular Traps Formation and Contributes to Blood–Brain Barrier Injury After Stroke

doi: 10.1002/cns.71239

Figure Lengend Snippet: C3a‐C3aR signaling was identified as a potential key regulator associated with NETs formation. (A, C) Heatmap of genes enriched regarding the NETs formation and complement cascade ( n = 3). C3 and C3aR are involved in complement cascade and NETs formation. (B) KDA provides that C3aR is a key driver in influencing the expression of other genes. (D) Quantification of mRNA of C1qa, C3, C3aR, C4, and C5 using RT‐qPCR 3 days after stroke ( n = 6 in the sham group, and n = 7 in the stroke group). (E) WB bands in 2 groups 3 days after stroke. (F–H) Protein expression of C1q, C3, and C3aR normalized to β‐actin ( n = 4). (I) C3aR expressed on the neutrophils. Scale bar = 50 μm or 20 μm (zoom). (J) The colocalization experiment showing the fluorescent signals of C3aR and HIS48. The density plot illustrates the fluorescence intensity in colocalized regions, indicating a spatial overlap. (K) Co‐IP results of C3aR and C3, showing an association between C3‐derived material and C3aR in tissue lysates. Stroke group versus sham group, data as mean ± SEM. * p < 0.05, ** p < 0.01, and *** p < 0.001.

Article Snippet: The purified human C3a (MCE, USA, catalog number: HY‐P7862) was dissolved in PBS (Phosphate‐buffered saline) at 10 μg/mL.

Techniques: Expressing, Quantitative RT-PCR, Fluorescence, Co-Immunoprecipitation Assay, Derivative Assay, Tissue

Inhibition of C3a‐C3aR signaling was associated with reduced NETs formation, BBB damage, and neurological impairment after stroke. (A) The flow diagram of an experiment in this part. The animals received intraperitoneal injections of the C3aR antagonist (C3aRA) SB290157 or vehicle for five consecutive days, starting 2 days before tMCAO. On day 3 after tMCAO, behavioral tests were performed, and brain tissue was harvested. (B, C) mNSS score ( n = 9) and MST ratio ( n = 7) in the vehicle and C3aRA groups. (D) Survival curve of the vehicle and C3aRA groups from day 0 to day 7 after stroke ( n = 9). (E) Trajectory plots and open field movement heatmap in the vehicle and C3aRA groups. (F, G) Average speed and total distance in the vehicle and C3aRA groups ( n = 7). (H) Survival rate in the vehicle and C3aRA groups ( n = 9). (I) Quantification of cfDNA in the blood of the vehicle and C3aRA groups ( n = 5). (J) Quantification of NETs in the vehicle and C3aRA groups ( n = 9 FOVs of 3 rats, 3 FOVs per rat). (K) Images of NETs in the vehicle and C3aRA groups. Scale bar = 50 μm or 20 μm (zoom). (L) WB bands of the vehicle and C3aRA groups. (M–P) Protein expression of C3aR, CitH3, Occludin, and ZO‐1 normalized to GAPDH or H3 ( n = 4). (Q) Image of BBB leakage using Evans blue dye in the vehicle and C3aRA groups. (R) Image of BBB leakage using biotin staining in the vehicle and C3aRA groups. Scale bar = 20 μm. (S) Images of CD31 co‐labeled with ZO‐1 or Occludin in the vehicle and C3aRA groups. Scale bar = 50 μm. (T, U) Quantification of Evans blue dye ( n = 4) and biotin staining ( n = 9 FOVs of 3 rats, 3 FOVs per rat) in the vehicle and C3aRA groups. (V, W) Quantification of CD31 co‐labeled with ZO‐1 or Occludin in the vehicle and C3aRA groups ( n = 9 FOVs of 3 rats, 3 FOVs per rat). (X) Ultrastructure alteration of the tight junction near the endothelial cell. Scale bar = 1 μm and 0.5 μm. C3aRA group versus vehicle group, data as mean ± SEM. * p < 0.05, ** p < 0.01, and *** p < 0.001.

Journal: CNS Neuroscience & Therapeutics

Article Title: C3a‐ C3aR Signaling Modulates Neutrophil Extracellular Traps Formation and Contributes to Blood–Brain Barrier Injury After Stroke

doi: 10.1002/cns.71239

Figure Lengend Snippet: Inhibition of C3a‐C3aR signaling was associated with reduced NETs formation, BBB damage, and neurological impairment after stroke. (A) The flow diagram of an experiment in this part. The animals received intraperitoneal injections of the C3aR antagonist (C3aRA) SB290157 or vehicle for five consecutive days, starting 2 days before tMCAO. On day 3 after tMCAO, behavioral tests were performed, and brain tissue was harvested. (B, C) mNSS score ( n = 9) and MST ratio ( n = 7) in the vehicle and C3aRA groups. (D) Survival curve of the vehicle and C3aRA groups from day 0 to day 7 after stroke ( n = 9). (E) Trajectory plots and open field movement heatmap in the vehicle and C3aRA groups. (F, G) Average speed and total distance in the vehicle and C3aRA groups ( n = 7). (H) Survival rate in the vehicle and C3aRA groups ( n = 9). (I) Quantification of cfDNA in the blood of the vehicle and C3aRA groups ( n = 5). (J) Quantification of NETs in the vehicle and C3aRA groups ( n = 9 FOVs of 3 rats, 3 FOVs per rat). (K) Images of NETs in the vehicle and C3aRA groups. Scale bar = 50 μm or 20 μm (zoom). (L) WB bands of the vehicle and C3aRA groups. (M–P) Protein expression of C3aR, CitH3, Occludin, and ZO‐1 normalized to GAPDH or H3 ( n = 4). (Q) Image of BBB leakage using Evans blue dye in the vehicle and C3aRA groups. (R) Image of BBB leakage using biotin staining in the vehicle and C3aRA groups. Scale bar = 20 μm. (S) Images of CD31 co‐labeled with ZO‐1 or Occludin in the vehicle and C3aRA groups. Scale bar = 50 μm. (T, U) Quantification of Evans blue dye ( n = 4) and biotin staining ( n = 9 FOVs of 3 rats, 3 FOVs per rat) in the vehicle and C3aRA groups. (V, W) Quantification of CD31 co‐labeled with ZO‐1 or Occludin in the vehicle and C3aRA groups ( n = 9 FOVs of 3 rats, 3 FOVs per rat). (X) Ultrastructure alteration of the tight junction near the endothelial cell. Scale bar = 1 μm and 0.5 μm. C3aRA group versus vehicle group, data as mean ± SEM. * p < 0.05, ** p < 0.01, and *** p < 0.001.

Article Snippet: The purified human C3a (MCE, USA, catalog number: HY‐P7862) was dissolved in PBS (Phosphate‐buffered saline) at 10 μg/mL.

Techniques: Inhibition, Tissue, Expressing, Staining, Labeling

Activation of C3a‐C3aR signaling was associated with increased NETs formation, BBB damage, and neurological impairment after stroke. (A) The flow diagram of an experiment in this part. The animals received intranasal administration of C3a or vehicle for seven consecutive days, starting 4 days before tMCAO. On day 3 after tMCAO, behavioral tests were performed, and brain tissue was harvested. (B, C) mNSS score ( n = 9) and MST ratio ( n = 7) in the control and C3a groups. (D) Total distance in the control and C3a groups ( n = 7). (E) Trajectory plots and open field movement heatmap in the control and C3a groups. (F) Average speed in the control and C3a groups ( n = 7). (G) Quantification of NETs in the control and C3a groups ( n = 9 FOVs of 3 rats, 3 FOVs per rat). (H) Levels of C3a in blood and cortex in the control and C3a groups ( n = 3). (I, J) Quantification of C3aR and CitH3 expression in the control and C3a groups ( n = 4). (K) Images of NETs in the control and C3a groups. Scale bar = 50 μm or 20 μm (zoom). (L) WB bands in the control and C3a groups. (M–O) Quantification of PAD4, ZO‐1, and Occludin expression in the control and C3a groups ( n = 4). (P) Image of BBB leakage using Evans blue dye in the control and C3a groups. (Q) Image of BBB leakage using biotin staining in the control and C3a groups. Scale bar = 20 μm. (R, S) Quantification of biotin staining ( n = 9 FOVs of 3 rats, 3 FOVs per rat) and Evans blue dye ( n = 4) in the control and C3a groups. (T) Images of CD31 co‐labeled with ZO‐1 or Occludin in the control and C3a groups. Scale bar =20 μm. (U, V) Quantification of CD31 co‐labeled with ZO‐1 or Occludin in the control and C3a groups ( n = 9 FOVs of 3 rats, 3 FOVs per rat). (W) Ultrastructure alteration of the tight junction near the endothelial cell. Scale bar = 1 μm or 0.5 μm (zoom). C3a group versus control group, data as mean ± SEM. * p < 0.05, ** p < 0.01, and *** p < 0.001.

Journal: CNS Neuroscience & Therapeutics

Article Title: C3a‐ C3aR Signaling Modulates Neutrophil Extracellular Traps Formation and Contributes to Blood–Brain Barrier Injury After Stroke

doi: 10.1002/cns.71239

Figure Lengend Snippet: Activation of C3a‐C3aR signaling was associated with increased NETs formation, BBB damage, and neurological impairment after stroke. (A) The flow diagram of an experiment in this part. The animals received intranasal administration of C3a or vehicle for seven consecutive days, starting 4 days before tMCAO. On day 3 after tMCAO, behavioral tests were performed, and brain tissue was harvested. (B, C) mNSS score ( n = 9) and MST ratio ( n = 7) in the control and C3a groups. (D) Total distance in the control and C3a groups ( n = 7). (E) Trajectory plots and open field movement heatmap in the control and C3a groups. (F) Average speed in the control and C3a groups ( n = 7). (G) Quantification of NETs in the control and C3a groups ( n = 9 FOVs of 3 rats, 3 FOVs per rat). (H) Levels of C3a in blood and cortex in the control and C3a groups ( n = 3). (I, J) Quantification of C3aR and CitH3 expression in the control and C3a groups ( n = 4). (K) Images of NETs in the control and C3a groups. Scale bar = 50 μm or 20 μm (zoom). (L) WB bands in the control and C3a groups. (M–O) Quantification of PAD4, ZO‐1, and Occludin expression in the control and C3a groups ( n = 4). (P) Image of BBB leakage using Evans blue dye in the control and C3a groups. (Q) Image of BBB leakage using biotin staining in the control and C3a groups. Scale bar = 20 μm. (R, S) Quantification of biotin staining ( n = 9 FOVs of 3 rats, 3 FOVs per rat) and Evans blue dye ( n = 4) in the control and C3a groups. (T) Images of CD31 co‐labeled with ZO‐1 or Occludin in the control and C3a groups. Scale bar =20 μm. (U, V) Quantification of CD31 co‐labeled with ZO‐1 or Occludin in the control and C3a groups ( n = 9 FOVs of 3 rats, 3 FOVs per rat). (W) Ultrastructure alteration of the tight junction near the endothelial cell. Scale bar = 1 μm or 0.5 μm (zoom). C3a group versus control group, data as mean ± SEM. * p < 0.05, ** p < 0.01, and *** p < 0.001.

Article Snippet: The purified human C3a (MCE, USA, catalog number: HY‐P7862) was dissolved in PBS (Phosphate‐buffered saline) at 10 μg/mL.

Techniques: Activation Assay, Tissue, Control, Expressing, Staining, Labeling

Effect of 10 Gy X‐ray on viability of NIH‐3T3, B16.F10, MDA‐MB‐231, and HepG2 cells. Blue: untreated controls; Pink: irradiated cells. Cell counts were conducted at 24, 48, and 72 h post‐treatment. Statistical analysis was performed using two‐way ANOVA with Tukey's post hoc test: p < 0.05 (*), p < 0.005 (**), p < 0.0005 (***), p < 0.0001 (****), n = 3. Note: Y ‐axes are scaled independently for each cell line to account for differences in baseline growth, allowing clearer visualization of treatment effects. Tumor cell counts and representative images can be found in Appendix Table and Figure .

Journal: MicrobiologyOpen

Article Title: Synergistic Effects of IMP‐1700, Ciprofloxacin, and X‐Ray Radiation in Bacteria and Mammalian Cell Lines: Implications for Use in Antimicrobial‐Resistant Bacteria

doi: 10.1002/mbo3.70270

Figure Lengend Snippet: Effect of 10 Gy X‐ray on viability of NIH‐3T3, B16.F10, MDA‐MB‐231, and HepG2 cells. Blue: untreated controls; Pink: irradiated cells. Cell counts were conducted at 24, 48, and 72 h post‐treatment. Statistical analysis was performed using two‐way ANOVA with Tukey's post hoc test: p < 0.05 (*), p < 0.005 (**), p < 0.0005 (***), p < 0.0001 (****), n = 3. Note: Y ‐axes are scaled independently for each cell line to account for differences in baseline growth, allowing clearer visualization of treatment effects. Tumor cell counts and representative images can be found in Appendix Table and Figure .

Article Snippet: The tumor cell lines, mouse melanoma B16.F10 (CRL‐6475, ATCC), human breast cancer MB‐MDA‐231 (CRM‐HTB‐26, ATCC), human hepatocellular carcinoma HepG2 C3A (a derivative of HepG2, CRL‐3581, ATCC), as well as the noncancerous mouse fibroblast cell line NIH‐3T3 (CRL‐1658, ATCC), were cultivated at 37°C, 5% CO2.

Techniques: Irradiation

Images of untreated NIH‐3T3, B16.F10, MDA‐MB‐231, and HepG2 cells and cells exposed to X‐ray. Scalebar: 300 µm.

Journal: MicrobiologyOpen

Article Title: Synergistic Effects of IMP‐1700, Ciprofloxacin, and X‐Ray Radiation in Bacteria and Mammalian Cell Lines: Implications for Use in Antimicrobial‐Resistant Bacteria

doi: 10.1002/mbo3.70270

Figure Lengend Snippet: Images of untreated NIH‐3T3, B16.F10, MDA‐MB‐231, and HepG2 cells and cells exposed to X‐ray. Scalebar: 300 µm.

Article Snippet: The tumor cell lines, mouse melanoma B16.F10 (CRL‐6475, ATCC), human breast cancer MB‐MDA‐231 (CRM‐HTB‐26, ATCC), human hepatocellular carcinoma HepG2 C3A (a derivative of HepG2, CRL‐3581, ATCC), as well as the noncancerous mouse fibroblast cell line NIH‐3T3 (CRL‐1658, ATCC), were cultivated at 37°C, 5% CO2.

Techniques:

Viability of NIH‐3T3, B16.F10, MDA‐MB‐231, and HepG2 cells after treatment with IMP‐1700 (5 µM), ciprofloxacin (CPX) (15 µM), their combination, or DMSO, with and without 10 Gy X‐ray. Cell counts were measured at 24, 48, and 72 h post‐treatment. Statistical significance assessed via two‐way ANOVA and Tukey's post hoc test: p < 0.05 (*), p < 0.005 (**), p < 0.0005 (***), p < 0.0001 (****), n = 3. Significant differences are only shown compared to untreated or 10 Gy. Tumor cell count values and images are available in Appendix Table and Figure , , , .

Journal: MicrobiologyOpen

Article Title: Synergistic Effects of IMP‐1700, Ciprofloxacin, and X‐Ray Radiation in Bacteria and Mammalian Cell Lines: Implications for Use in Antimicrobial‐Resistant Bacteria

doi: 10.1002/mbo3.70270

Figure Lengend Snippet: Viability of NIH‐3T3, B16.F10, MDA‐MB‐231, and HepG2 cells after treatment with IMP‐1700 (5 µM), ciprofloxacin (CPX) (15 µM), their combination, or DMSO, with and without 10 Gy X‐ray. Cell counts were measured at 24, 48, and 72 h post‐treatment. Statistical significance assessed via two‐way ANOVA and Tukey's post hoc test: p < 0.05 (*), p < 0.005 (**), p < 0.0005 (***), p < 0.0001 (****), n = 3. Significant differences are only shown compared to untreated or 10 Gy. Tumor cell count values and images are available in Appendix Table and Figure , , , .

Article Snippet: The tumor cell lines, mouse melanoma B16.F10 (CRL‐6475, ATCC), human breast cancer MB‐MDA‐231 (CRM‐HTB‐26, ATCC), human hepatocellular carcinoma HepG2 C3A (a derivative of HepG2, CRL‐3581, ATCC), as well as the noncancerous mouse fibroblast cell line NIH‐3T3 (CRL‐1658, ATCC), were cultivated at 37°C, 5% CO2.

Techniques: Cell Characterization

Images of NIH‐3T3, B16.F10, MDA‐MB‐231, and HepG2 cells treated with IMP‐1700, with and without X‐ray. Scalebar: 300 µm.

Journal: MicrobiologyOpen

Article Title: Synergistic Effects of IMP‐1700, Ciprofloxacin, and X‐Ray Radiation in Bacteria and Mammalian Cell Lines: Implications for Use in Antimicrobial‐Resistant Bacteria

doi: 10.1002/mbo3.70270

Figure Lengend Snippet: Images of NIH‐3T3, B16.F10, MDA‐MB‐231, and HepG2 cells treated with IMP‐1700, with and without X‐ray. Scalebar: 300 µm.

Article Snippet: The tumor cell lines, mouse melanoma B16.F10 (CRL‐6475, ATCC), human breast cancer MB‐MDA‐231 (CRM‐HTB‐26, ATCC), human hepatocellular carcinoma HepG2 C3A (a derivative of HepG2, CRL‐3581, ATCC), as well as the noncancerous mouse fibroblast cell line NIH‐3T3 (CRL‐1658, ATCC), were cultivated at 37°C, 5% CO2.

Techniques:

Images of NIH‐3T3, B16.F10, MDA‐MB‐231, and HepG2 cells treated with ciprofloxacin (CPX), with and without X‐ray. Scalebar: 300 µm.

Journal: MicrobiologyOpen

Article Title: Synergistic Effects of IMP‐1700, Ciprofloxacin, and X‐Ray Radiation in Bacteria and Mammalian Cell Lines: Implications for Use in Antimicrobial‐Resistant Bacteria

doi: 10.1002/mbo3.70270

Figure Lengend Snippet: Images of NIH‐3T3, B16.F10, MDA‐MB‐231, and HepG2 cells treated with ciprofloxacin (CPX), with and without X‐ray. Scalebar: 300 µm.

Article Snippet: The tumor cell lines, mouse melanoma B16.F10 (CRL‐6475, ATCC), human breast cancer MB‐MDA‐231 (CRM‐HTB‐26, ATCC), human hepatocellular carcinoma HepG2 C3A (a derivative of HepG2, CRL‐3581, ATCC), as well as the noncancerous mouse fibroblast cell line NIH‐3T3 (CRL‐1658, ATCC), were cultivated at 37°C, 5% CO2.

Techniques:

Images of NIH‐3T3, B16.F10, MDA‐MB‐231, and HepG2 cells treated with IMP‐1700 and ciprofloxacin (CPX), with and without X‐ray. Scalebar: 300 µm.

Journal: MicrobiologyOpen

Article Title: Synergistic Effects of IMP‐1700, Ciprofloxacin, and X‐Ray Radiation in Bacteria and Mammalian Cell Lines: Implications for Use in Antimicrobial‐Resistant Bacteria

doi: 10.1002/mbo3.70270

Figure Lengend Snippet: Images of NIH‐3T3, B16.F10, MDA‐MB‐231, and HepG2 cells treated with IMP‐1700 and ciprofloxacin (CPX), with and without X‐ray. Scalebar: 300 µm.

Article Snippet: The tumor cell lines, mouse melanoma B16.F10 (CRL‐6475, ATCC), human breast cancer MB‐MDA‐231 (CRM‐HTB‐26, ATCC), human hepatocellular carcinoma HepG2 C3A (a derivative of HepG2, CRL‐3581, ATCC), as well as the noncancerous mouse fibroblast cell line NIH‐3T3 (CRL‐1658, ATCC), were cultivated at 37°C, 5% CO2.

Techniques:

Images of NIH‐3T3, B16.F10, MDA‐MB‐231, and HepG2 cells treated with DMSO, with and without X‐ray. Scalebar: 300 µm.

Journal: MicrobiologyOpen

Article Title: Synergistic Effects of IMP‐1700, Ciprofloxacin, and X‐Ray Radiation in Bacteria and Mammalian Cell Lines: Implications for Use in Antimicrobial‐Resistant Bacteria

doi: 10.1002/mbo3.70270

Figure Lengend Snippet: Images of NIH‐3T3, B16.F10, MDA‐MB‐231, and HepG2 cells treated with DMSO, with and without X‐ray. Scalebar: 300 µm.

Article Snippet: The tumor cell lines, mouse melanoma B16.F10 (CRL‐6475, ATCC), human breast cancer MB‐MDA‐231 (CRM‐HTB‐26, ATCC), human hepatocellular carcinoma HepG2 C3A (a derivative of HepG2, CRL‐3581, ATCC), as well as the noncancerous mouse fibroblast cell line NIH‐3T3 (CRL‐1658, ATCC), were cultivated at 37°C, 5% CO2.

Techniques: